A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.

Absci Corporation ABSI

Promising (early) Emerging Frontier sector · Absci — generative-AI antibody drug design, early-stage and speculative.

🗓 Reports earnings in 41 days (2026-11-16) — calendar context, not a prediction.

Absci Corporation (ABSI) is an early-stage Emerging Frontier company, graded Promising (early) on FrontierLab's evidence-based quality rubric (data as of 2026-10-05). Gross-profits-to-assets is -0.01; Rule of 40 is -8473.6. Net share issuance 23.4% YoY (heavy issuance). 3 risk flags are noted below. Analyst mix: 14 buy / 2 hold / 0 sell. Track record: 27% of Early-stage-graded names beat the S&P over 63 sessions (95% CI 15–44%, N=33). Median excess vs the S&P was -14.6%.

These sentences are generated from the day's data by deterministic templates.

Key quality signals

Revenue growth (YoY)	—
Gross margin	—
Gross profits / assets	-0.01
Rule of 40	-8473.6
Net margin	-8411.3%
Cash runway (months)	22.3
PEG	—
Price / sales	1201.3

Quality checklist

Each line is one quality test behind the grade — ✓ passed · ~ borderline · ✗ failed. Hover a metric in the tables below for what it means.

✓ Capital efficiency
✓ Share dilution — 23.4%
✗ Competitive moat — None
✓ Market size (TAM) — Large

Grade history

2026-08-18 — Promising (early) (from Mixed (early))
2026-06-10 — Mixed (early) (first graded)

Every grade change since FrontierLab began tracking this name — the receipts behind the current grade.

How have Early-stage-graded names performed?

The forward returns of all Early-stage-graded names since each grade was recorded — the bucket this name currently sits in, not a forecast of this individual stock.

Window	Forward record vs the S&P	Median
~1 month	45% of Early-stage-graded names beat the S&P over 21 sessions (95% CI 29–62%, N=31).	Median excess vs the S&P was -3.2%.
~3 months	27% of Early-stage-graded names beat the S&P over 63 sessions (95% CI 15–44%, N=33).	Median excess vs the S&P was -14.6%.
~6 months	building — 46 more sessions needed

How have this name's flags scored?

Flag	N	Mean excess vs S&P
Burning cash — operating margin is negative.	36	-6.5%
Heavy dilution (~23%/yr) — top-decile share issuers have historically underperformed.	sample still too small to report (need ≥ 8)
Parabolic one-day spike (+15%) in the last month — extreme single-day moves tend to mean-revert.	sample still too small to report (need ≥ 8)

These per-flag figures are observational — a flag firing is not a randomized assignment, so any edge can reflect what kind of names trip a flag, not the flag itself. Descriptive, not causal.

Scope: these are forward returns vs the S&P among names still covered at each horizon's end, within the curated universe — not a survivorship-clean whole-market backtest. Names later dropped from coverage are counted as attrition (not hidden), and single-session moves beyond ±300% are treated as split/data artifacts and excluded. How this is measured → · Full track record →

Fundamentals

Market cap	$1.88B
Stage	Early
Share issuance (YoY)	23.4% · heavy issuance
Moat	None
TAM	LARGE
P/E (trailing)	—
EPS (trailing)	$-0.80
Burn multiple	—
Gross-margin trend (pts)	—
Cash / assets	0.75
Accruals (%)	-5.4%
Net debt / EBITDA	—
Statements as of	Q2 FY2026 · filed 2026-08-11

Momentum context — describes the past, not a signal

52-week range

$2.24$12.06

Low reached Mar 12, 2026 · high reached Jul 2, 2026 — by daily close.

Price	$11.07 (as of 2026-10-02)
Last session move	—
% off 52-wk high	-8.2%
RSI (14)	64
Relative volume	0.8×

Risk flags

Burning cash — operating margin is negative.Heavy dilution (~23%/yr) — top-decile share issuers have historically underperformed.Parabolic one-day spike (+15%) in the last month — extreme single-day moves tend to mean-revert.

Analyst mix

Strong buy	4
Buy	10
Hold	2
Sell	0
Strong sell	0

Ratings are context, not a price target. "Momentum" = how the mix changed over recent weeks, not a forecast.

AI take — daily, AI-generated

AI leans cautious

Early-stage with no visible financials and negative profitability per asset; too speculative without proof of concept.

Generated by an AI model from the day's news — an opinion for context only. Not financial advice, not a recommendation, and not a price target.

Similar Emerging Frontier names

Centrus Energy Corp.Kratos Defense & Security Solutions, Inc.BigBear.ai Holdings, Inc.SoundHound AI, Inc.Nano Nuclear Energy Inc.Ouster, Inc.

← All Emerging Frontier names · Open ABSI in the interactive screener →

Data as of 2026-10-05 08:19 (end-of-day). How grades are computed →